4.7 Review

Neuroplastic alterations in cannabinoid receptors type 1 (CB1) in animal models of epileptic seizures

Related references

Note: Only part of the references are listed.
Review Neurosciences

Targeting Endocannabinoid System in Epilepsy: For Good or for Bad

Christopher Martinez-Aguirre et al.

Summary: Epilepsy is a common neurological disorder worldwide. Recent studies have shown that the use of cannabinoids and activation of the endocannabinoid system (ECS) can be a therapeutic strategy for controlling epilepsy. However, there are controversial findings regarding the effects of ECS activation.

NEUROSCIENCE (2022)

Article Biochemistry & Molecular Biology

Increased TRPV1 Channels and FosB Protein Expression Are Associated with Chronic Epileptic Seizures and Anxiogenic-like Behaviors in a Preclinical Model of Temporal Lobe Epilepsy

Willian Lazarini-Lopes et al.

Summary: This study investigated the impact of chronic epileptic seizures on anxiety-like behavior and TRPV1 channel expression in a genetic model of epilepsy. The results showed increased anxiety-like behavior in the model rats and alterations in TRPV1 expression in brain structures involved with epilepsy and anxiety comorbidity.

BIOMEDICINES (2022)

Article Neurosciences

The endocannabinoid system impacts seizures in a mouse model of Dravet syndrome

Lyndsey L. Anderson et al.

Summary: Deficiency in the endocannabinoid system may contribute to seizure phenotypes in Dravet syndrome, and enhancing endocannabinoid tone could be anticonvulsant.

NEUROPHARMACOLOGY (2022)

Review Neurosciences

Cannabidiol: pharmacology and therapeutic targets

Stevie C. Britch et al.

Summary: CBD products are commonly used for self-treatment without regulatory approval, with limited scientific evidence from clinical trials. Epidiolex is the only rigorously evaluated product approved for intractable childhood-onset seizures, while studies on CBD for other medical conditions are limited in number and often lack scientific rigor.

PSYCHOPHARMACOLOGY (2021)

Review Behavioral Sciences

Cannabinoids in Audiogenic Seizures: From Neuronal Networks to Future Perspectives for Epilepsy Treatment

Willian Lazarini-Lopes et al.

Summary: Cannabinoids and Cannabis-derived compounds play a significant role in epilepsy research, including modulation of the endocannabinoid system and anticonvulsant activity. Animal models such as audiogenic seizure-prone rats are useful for studying epilepsy.

FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2021)

Review Biochemistry & Molecular Biology

Rodent Brain Pathology, Audiogenic Epilepsy

Irina B. Fedotova et al.

Summary: The review discusses the internal relationship between stages of rodent audiogenic seizures and post-ictal catalepsy, highlighting a potential platform for studying epileptogenesis mechanisms. It suggests that the wild run stage of audiogenic seizure could be seen as an intense panic reaction, supported by experimental data. This phenomenon is of interest to physiologists due to rodents' sensitivity to dangerous sound stimuli.

BIOMEDICINES (2021)

Review Environmental Sciences

Efficacy of Phytocannabinoids in Epilepsy Treatment: Novel Approaches and Recent Advances

Aaron M. Farrelly et al.

Summary: Epilepsy is a neurological disorder characterized by recurrent seizures, for which there is currently no cure. Some patients with treatment-resistant epilepsy may benefit from alternative treatments such as phytocannabinoids. Research into the therapeutic potential of phytocannabinoids, particularly Delta(9)-THC, has gained attention but further investigation is needed.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Article Behavioral Sciences

Chronic cannabidiol (CBD) administration induces anticonvulsant and antiepileptogenic effects in a genetic model of epilepsy

Willian Lazarini-Lopes et al.

Summary: Chronic administration of CBD in a genetic model of epilepsy showed anticonvulsant and antiepileptogenic effects by reducing brainstem and tonic-clonic seizures, preventing limbic recruitment, and suppressing limbic seizures. CBD also prevented chronic neuronal hyperactivity and modulated the expression of CB1R in key brain structures associated with seizures. These results support the chronic use of CBD for epilepsy treatments.

EPILEPSY & BEHAVIOR (2021)

Article Neurosciences

Positive allosteric modulation of type 1 cannabinoid receptors reduces spike-and-wave discharges in Genetic Absence Epilepsy Rats from Strasbourg

Andrew J. Roebuck et al.

Summary: Research suggests that current treatments for CAE are not always effective, and modulation of certain cannabinoids and the CB1R receptor may offer more promising pharmacological treatments for absence seizures.

NEUROPHARMACOLOGY (2021)

Review Neurosciences

Pharmacoresistance - Epidemiology, mechanisms, and impact on epilepsy treatment

Mubeen Janmohamed et al.

NEUROPHARMACOLOGY (2020)

Review Clinical Neurology

The Endocannabinoid System and Synthetic Cannabinoids in Preclinical Models of Seizure and Epilepsy

Anna-Maria Smolyakova et al.

JOURNAL OF CLINICAL NEUROPHYSIOLOGY (2020)

Review Clinical Neurology

Dravet Syndrome: A Review of Current Management

James W. Wheless et al.

PEDIATRIC NEUROLOGY (2020)

Review Behavioral Sciences

The anticonvulsant effects of cannabidiol in experimental models of epileptic seizures: From behavior and mechanisms to clinical insights

Willian Lazarini-Lopes et al.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2020)

Review Clinical Neurology

Current understanding of febrile seizures and their long-term outcomes

Leena D. Mewasingh et al.

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2020)

Article Multidisciplinary Sciences

Dual mechanism of TRKB activation by anandamide through CB1 and TRPV1 receptors

Cassiano R. A. F. Diniz et al.

PEERJ (2019)

Article Multidisciplinary Sciences

Descending projections from the substantia nigra pars reticulata differentially control seizures

Evan Wicker et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Article Clinical Neurology

Cannabinoid receptor 1/2 double-knockout mice develop epilepsy

Shane Rowley et al.

EPILEPSIA (2017)

Review Behavioral Sciences

Cannabinoids in treatment-resistant epilepsy: A review

Brooke K. O'Connell et al.

EPILEPSY & BEHAVIOR (2017)

Article Biochemistry & Molecular Biology

Animal Models of Seizures and Epilepsy: Past, Present, and Future Role for the Discovery of Antiseizure Drugs

Wolfgang Loscher

NEUROCHEMICAL RESEARCH (2017)

Article Multidisciplinary Sciences

Cannabinoid antagonist SLV326 induces convulsive seizures and changes in the interictal EEG in rats

Martin F. J. Perescis et al.

PLOS ONE (2017)

Review Clinical Neurology

Psychiatric comorbidities in new onset epilepsy: Should they be always investigated?

Andres M. Kanner

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2017)

Review Clinical Neurology

Prevalence and Incidence of Drug-Resistant Mesial Temporal Lobe Epilepsy in the United States

Ali A. Asadi-Pooya et al.

WORLD NEUROSURGERY (2017)

Review Pharmacology & Pharmacy

Translating Endocannabinoid Biology into Clinical Practice: Cannabidiol for Stroke Prevention

Eugene L. Scharf

CANNABIS AND CANNABINOID RESEARCH (2017)

Article Behavioral Sciences

Time course evaluation of behavioral impairments in the pilocarpine model of epilepsy

Mark William Lopes et al.

EPILEPSY & BEHAVIOR (2016)

Article Immunology

TRPV1 promotes repetitive febrile seizures by pro-inflammatory cytokines in immature brain

Wen-Xian Huang et al.

BRAIN BEHAVIOR AND IMMUNITY (2015)

Review Clinical Neurology

Cannabinoids and Epilepsy

Evan C. Rosenberg et al.

NEUROTHERAPEUTICS (2015)

Article Pharmacology & Pharmacy

Long-term disease-modifying effect of the endocannabinoid agonist WIN55,212-2 in a rat model of audiogenic epilepsy

Lyudmila V. Vinogradova et al.

PHARMACOLOGICAL REPORTS (2015)

Review Pharmacology & Pharmacy

Phytocannabinoids and epilepsy

R. G. dos Santos et al.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2015)

Article Clinical Neurology

ILAE Official Report: A practical clinical definition of epilepsy

Robert S. Fisher et al.

EPILEPSIA (2014)

Review Neurosciences

ROLE OF BLOOD-BRAIN BARRIER IN TEMPORAL LOBE EPILEPSY AND PHARMACORESISTANCE

E. A. van Vliet et al.

NEUROSCIENCE (2014)

Article Multidisciplinary Sciences

Modulation of Pilocarpine-Induced Seizures by Cannabinoid Receptor 1

Rebecca L. Kow et al.

PLOS ONE (2014)

Review Clinical Neurology

Animal models of epilepsy: use and limitations

Ludmyla Kandratavicius et al.

NEUROPSYCHIATRIC DISEASE AND TREATMENT (2014)

Article Veterinary Sciences

Alterations of endocannabinoids in cerebrospinal fluid of dogs with epileptic seizure disorder

Felix K. Gesell et al.

BMC VETERINARY RESEARCH (2013)

Review Neurosciences

Adenosine dysfunction in epilepsy

Detlev Boison

Article Neurosciences

R6/2 Huntington's Disease Mice Develop Early and Progressive Abnormal Brain Metabolism and Seizures

Efrain Cepeda-Prado et al.

JOURNAL OF NEUROSCIENCE (2012)

Article Clinical Neurology

Cannabinoid modulation of the dopaminergic circuitry: Implications for limbic and striatal output

Megan L. Fitzgerald et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2012)

Article Clinical Neurology

Pro-epileptic effects of the cannabinoid receptor antagonist SR141716 in a model of audiogenic epilepsy

Lyudmila V. Vinogradova et al.

EPILEPSY RESEARCH (2011)

Article Multidisciplinary Sciences

Capsaicin-Induced Changes in LTP in the Lateral Amygdala Are Mediated by TRPV1

Carsten Zschenderlein et al.

PLOS ONE (2011)

Article Neurosciences

Temperature-induced opening of TRPV1 ion channel is stabilized by the pore domain

Joerg Grandl et al.

NATURE NEUROSCIENCE (2010)

Letter Clinical Neurology

Rimonabant induces partial seizures in a patient with a history of generalized epilepsy

Hilde M. H. Braakman et al.

EPILEPSIA (2009)

Review Biochemistry & Molecular Biology

Post-ischemic brain damage: the endocannabinoid system in the mechanisms of neuronal death

Domenico E. Pellegrini-Giampietro et al.

FEBS JOURNAL (2009)

Review Neurosciences

THE ENDOCANNABINOID SYSTEM AS A TARGET FOR NOVEL ANXIOLYTIC AND ANTIDEPRESSANT DRUGS

Silvana Gaetani et al.

ADVANCES IN NEUROPHARMACOLOGY (2009)

Review Biochemistry & Molecular Biology

Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond

Roger G. Pertwee

ADDICTION BIOLOGY (2008)

Review Biochemical Research Methods

The pilocarpine model of temporal lobe epilepsy

Giulia Curia et al.

JOURNAL OF NEUROSCIENCE METHODS (2008)

Review Biochemistry & Molecular Biology

Endocannabinoid signaling as a synaptic circuit breaker in neurological disease

Istvan Katona et al.

NATURE MEDICINE (2008)

Article Biochemistry & Molecular Biology

Experimental febrile seizures are precipitated by a hyperthermia-induced respiratory alkalosis

Sebastian Schuchmann et al.

NATURE MEDICINE (2006)

Article Behavioral Sciences

Behavioral characteristics of WAG/Rij rats susceptible and non-susceptible to audiogenic seizures

KY Sarkisova et al.

BEHAVIOURAL BRAIN RESEARCH (2006)

Review Behavioral Sciences

Global and focal aspects of absence epilepsy: The contribution of genetic models

Gilles van Luijtelaar et al.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2006)

Article Biochemistry & Molecular Biology

Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels

M van der Stelt et al.

EMBO JOURNAL (2005)

Article Neurosciences

Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain

A Tóth et al.

MOLECULAR BRAIN RESEARCH (2005)

Article Biochemistry & Molecular Biology

Structure, expression and regulation of the cannabinoid receptor gene (CB1) in Huntington's disease transgenic mice

EA McCaw et al.

EUROPEAN JOURNAL OF BIOCHEMISTRY (2004)

Article Multidisciplinary Sciences

CB1 cannabinoid receptors and on-demand defense against excitotoxicity

G Marsicano et al.

SCIENCE (2003)

Article Pharmacology & Pharmacy

The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy

MJ Wallace et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)

Review Neurosciences

Interneuron diversity series: Rhythm and mood in perisomatic inhibition

TF Freund

TRENDS IN NEUROSCIENCES (2003)

Article Neurosciences

Sex differences in models of temporal lobe epilepsy:: role of testosterone

CA Mejías-Aponte et al.

BRAIN RESEARCH (2002)

Article Clinical Neurology

New insights from the use of pilocarpine and kainate models

JP Leite et al.

EPILEPSY RESEARCH (2002)

Review Neurosciences

Childhood absence epilepsy: Genes, channels, neurons and networks

V Crunelli et al.

NATURE REVIEWS NEUROSCIENCE (2002)

Article Neurosciences

Cannabinoids inhibit striatonigral gabaergic neurotransmission in the mouse

I Wallmichrath et al.

NEUROSCIENCE (2002)

Review Multidisciplinary Sciences

Molecular mechanisms of nociception

D Julius et al.

NATURE (2001)

Article Medicine, General & Internal

A randomized, controlled trial of surgery for temporal-lobe epilepsy

S Wiebe et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)

Article Clinical Neurology

Mesial temporal lobe epilepsy: What have we learned?

J Engel

NEUROSCIENTIST (2001)

Review Neurosciences

Tonic and burst firing: dual modes of thalamocortical relay

SM Sherman

TRENDS IN NEUROSCIENCES (2001)

Review Behavioral Sciences

Developmental and genetic audiogenic seizure models: behavior and biological substrates

KC Ross et al.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2000)

Article Neurosciences

Role of the superior colliculus in the motor effects of cannabinoids and dopamine

MC Sañudo-Peña et al.

BRAIN RESEARCH (2000)